Scarica l'app Stockscreener
3.98
8.72%
-0.38
Pre-mercato:
3.97
-0.010
-0.25%
Precedente Chiudi:
$4.36
Aprire:
$4.36
Volume 24 ore:
50,783
Relative Volume:
0.58
Capitalizzazione di mercato:
$22.82M
Reddito:
$4.17M
Utile/perdita netta:
$-27.71M
Rapporto P/E:
-10.76
EPS:
-0.37
Flusso di cassa netto:
$-22.23M
1 W Prestazione:
-8.92%
1M Prestazione:
-20.06%
6M Prestazione:
-64.58%
1 anno Prestazione:
-79.90%
Intervallo 1D:
$3.98
$4.36
Intervallo di 1 settimana:
$3.98
$4.50
Portata 52W:
$3.32
$19.95
Clearside Biomedical Inc Stock (CLSD) Company Profile
Nome
Clearside Biomedical Inc
Settore
Industria
Telefono
678-270-3631
Indirizzo
900 NORTH POINT PARKWAY, ALPHARETTA, GA
Confronta CLSD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CLSD
Clearside Biomedical Inc
|
3.98 | 22.82M | 4.17M | -27.71M | -22.23M | -0.37 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Clearside Biomedical Inc Stock (CLSD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-18 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| 2025-07-18 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-07-18 | Downgrade | Stifel | Buy → Hold |
| 2024-08-21 | Iniziato | Chardan Capital Markets | Buy |
| 2024-06-25 | Iniziato | Oppenheimer | Outperform |
| 2021-12-15 | Ripresa | Wedbush | Outperform |
| 2021-07-29 | Iniziato | H.C. Wainwright | Buy |
| 2020-05-13 | Iniziato | ROTH Capital | Buy |
| 2019-08-09 | Downgrade | Needham | Buy → Hold |
| 2018-11-05 | Downgrade | Cowen | Outperform → Market Perform |
| 2018-11-05 | Downgrade | JP Morgan | Overweight → Underweight |
| 2018-11-05 | Downgrade | Stifel | Buy → Hold |
| 2018-03-06 | Reiterato | Needham | Buy |
| 2017-05-25 | Iniziato | JMP Securities | Mkt Outperform |
| 2017-02-24 | Iniziato | JP Morgan | Overweight |
| 2016-11-10 | Reiterato | Needham | Buy |
| 2016-10-24 | Reiterato | Stifel | Buy |
Mostra tutto
Clearside Biomedical Inc Borsa (CLSD) Ultime notizie
Clearside Biomedical Inc. stock daily chart insightsRisk Management & Daily Risk Controlled Trade Plans - newser.com
Is Clearside Biomedical Inc CLM a good long term investmentInsider Selling Patterns & Low Entry Investment Ideas - earlytimes.in
Will Clearside Biomedical Inc. stock go up soonJuly 2025 Retail & Growth Focused Stock Reports - newser.com
Evaluating Clearside Biomedical Inc. with trendline analysis2025 Bull vs Bear & Smart Money Movement Alerts - newser.com
How institutional ownership impacts Clearside Biomedical Inc. stockMarket Activity Recap & Scalable Portfolio Growth Ideas - newser.com
Clearside Biomedical Regains Nasdaq Compliance as of October 2025 - MSN
What analysts say about Clearside Biomedical Inc CLM stockGrowth Stock Opportunities & Beat the Market with AI Reports - earlytimes.in
Is Clearside Biomedical Inc. meeting your algorithmic filter criteriaJuly 2025 Sector Moves & Risk Controlled Stock Alerts - newser.com
Is Clearside Biomedical Inc. (CLM) stock a buy on weaknessPortfolio Return Report & Fast Momentum Stock Entry Tips - newser.com
Real time breakdown of Clearside Biomedical Inc. stock performance2025 Trading Volume Trends & Community Trade Idea Sharing - newser.com
Using data filters to optimize entry into Clearside Biomedical Inc.Weekly Trend Summary & Community Trade Idea Sharing Platform - newser.com
How Clearside Biomedical Inc. (CLM) stock reacts to stronger dollarTrade Analysis Summary & Free Technical Pattern Based Buy Signals - newser.com
Is a relief rally coming for Clearside Biomedical Inc. holdersInsider Selling & Free Verified High Yield Trade Plans - newser.com
Is Clearside Biomedical Inc. stock poised for growthCEO Change & Long-Term Capital Growth Strategies - newser.com
Earnings visualization tools for Clearside Biomedical Inc.Jobs Report & AI Driven Stock Movement Reports - newser.com
Clearside Biomedical (CLSD) Price Target Increased by 1,400.00% to 64.26 - MSN
Is RR Metalmakers India Limited a Reliable Dividend Payer for Income InvestorsTop Performing Stocks & Free Significant Capital Appreciation - earlytimes.in
Published on: 2025-09-29 15:28:03 - newser.com
Visualizing Clearside Biomedical Inc. stock with heatmapsJuly 2025 Recap & Community Verified Trade Signals - newser.com
Clearside Biomedical Inc Azioni (CLSD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Clearside Biomedical Inc Azioni (CLSD) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Chong Ngai Hang Victor | Chief Medical Officer |
Nov 01 '24 |
Buy |
1.00 |
36,500 |
36,500 |
100,000 |
5.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):